Prevalence of undiagnosed metabolic syndrome in a population of adult asymptomatic subjects



      To evaluate in the general population the prevalence of undiagnosed metabolic syndrome (MS), defined according to the National Cholesterol Education Program (NCEP) and International Diabetes Federation (IDF) criteria.


      A population-based cross-sectional study of 1175 asymptomatic adults in North-Western Italy.


      The prevalence of undiagnosed MS was 16.4% (95% CI = 14.4–18.6) (NCEP) and 28.0% (25.4–30.6) (IDF), respectively, 5.2% (3.6–7.3) and 8.9% (6.6–11.3) in normal-BMI and 26.6% (23.3–30.2) and 45.3% (41.3–49.2) in overweight/obese individuals. Of the total cohort, 52% were overweight/obese and they accounted for 85% of the cases of MS; a further 19% were normal weight with light physical activity and accounted, respectively, for 12% (NCEP) and 13% (IDF) of the cases. Only 25% (NCEP) and 14% (IDF) of participants showed no component of the MS (respectively, 40 and 26% of those not-overweight and 11 and 3% of those overweight/obese).


      More than 97% of unknown MS cases would be identified among apparently healthy individuals when overweight/obese, and normal-BMI subjects with low physical activity were screened. These two criteria might, therefore, be used to prioritise screening programmes in asymptomatic subjects, since even apparently healthy individuals, who are not-overweight, frequently show one or more metabolic abnormalities, whose co-existence has been demonstrated to be hazardous.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Diabetes Research and Clinical Practice
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Christensen J.O.
        • Sandbæk A.
        • Lauritzen T.
        • Borch-Johnsen K.
        Population-based stepwise screening for unrecognised type 2 diabetes is ineffective in general practice despite reliable algorithms.
        Diabetologia. 2004; 47: 1566-1573
        • Lakka H.M.
        • Laaksonen D.E.
        • Lakka T.A.
        • Niskanen L.K.
        • Kumpusalo E.
        • Tuomilehto J.
        • et al.
        The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men.
        JAMA. 2002; 288: 2709-2716
        • Gale E.A.M.
        The myth of the metabolic syndrome.
        Diabetologia. 2005; 48: 1679-1683
        • Kahn R.
        • Buse J.
        • Ferranini E.
        • Stern M.
        The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes.
        Diab. Care. 2005; 28: 2289-2304
        • Bo S.
        • Gentile L.
        • Ciccone G.
        • Baldi C.
        • Benini L.
        • Dusio F.
        • et al.
        The metabolic syndrome and high C-reactive protein: prevalence and difference by sex in a southern-European population-based cohort.
        Diab. Metab. Res. Rev. 2005; 21: 515-524
        • The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
        Report of the expert committee on the diagnosis and classification of diabetes Mellitus.
        Diab. Care. 2003; 26: S5-S20
        • Saltin B.
        • Grimby G.
        Physiological analysis of middle-aged and old former athletes. Comparison with still active athletes of the same ages.
        Circulation. 1968; 38: 1104-1115
        • National Institute of Health
        Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III).
        JAMA. 2001; 285: 2486-2497
      1. International Diabetes Federation, The IDF consensus worldwide definition of the metabolic syndrome (2005) available from

        • Ridker P.M.
        • Buring J.E.
        • Cook N.R.
        • Rifai N.
        C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events.
        Circulation. 2003; 107: 391-397
        • Bo S.
        • Gambino R.
        • Uberti B.
        • Mangiameli M.P.
        • Colosso G.
        • Repetti E.
        • et al.
        Does C-reactive protein identify a subclinical metabolic disease in healthy subjects?.
        Eur. J. Clin. Invest. 2005; 35: 265-270